Robert F. Kennedy, Jr, will lead the nation’s largest health and human services agency after today’s US Senate vote. Many ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...

Physicians are increasingly enthusiastic about the future of artificial intelligence (AI) in healthcare generally and in ...

Funding freezes, legal fights, chaos — no one in medical research knows what will come, except that as of January 22, 2025, ...

The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!

The MHRA has eased sodium valproate restrictions for men, dropping dual specialist reviews for current patients.

Alerts delivered via the electronic health record temporarily reduces unnecessary screening and treatment but does not create ...

Fourth-year medical students discuss skills learned beyond formal instruction; the things med school doesn’t teach.

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

A fatal explosion at a Michigan clinic has raised concerns about the growing use of hyperbaric oxygen therapy.

Cannabis use disorder requiring hospital-based care is linked to an increased risk for premature death in a new cohort study.